相关实验视频
Updated: Jul 15, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
关于布普伦诺芬剂量限制的证据:一项审查
Lucinda A Grande1, Dave Cundiff, Mark K Greenwald
1From the Pioneer Family Practice, Lacey, and University of Washington School of Medicine Department of Family Medicine, Seattle, WA (LAG); Smart Moves Integrated Health Services, Ilwaco, WA (DC, MM); Wayne State University, Detroit, MI (MKG); University of California San Francisco, San Francisco, CA (TEW); and Boulder Care, Portland, OR and UMass Chan Medical School, Worcester, MA (SAM).
优化布普伦诺芬剂量对于治疗阿片类药物使用障碍和预防过量死亡至关重要. 研究支持高达32毫克/天的剂量,挑战目前的FDA限制以改善患者的治疗结果.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 芬太尼过量死亡人数正在上升,有效的阿片类药物使用障碍 (OUD) 治疗的重要性正在增加.
- 布普伦诺芬是减少OUD过量死亡率的重要药物,取决于患者持续参与治疗.
- 目前的食品和药物管理局 (FDA) 准则限制了布普伦诺芬的剂量,可能会阻碍治疗的疗效.
结论:
- 鉴于芬太尼危机,FDA目前的布普伦诺芬剂量建议已经过时,可能有害.
- 更新布诺芬标签以推剂量高达32毫克/天,并删除16毫克/天的目标剂量,将提高治疗的有效性.
- 修订后的剂量指南有可能通过改善OUD患者的治疗结果来挽救生命.
相关概念视频
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Drug Response: Overview
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Abuse and Addiction: Pharmacological Phenomena
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Desensitization and Tachyphylaxis

